PRAXIS PRECISION MEDICINES I

About

Praxis Precision Medicines is a clinical-stage biopharmaceutical company focused on developing therapies for central nervous system disorders by leveraging genetic insights. The company utilizes a precision medicine approach to discover and advance small molecule treatments intended to address the underlying causes of neurological conditions, including movement disorders, epilepsy, and pain. Praxis aims to fill significant unmet medical needs by targeting specific patient populations defined by genetic markers or disease biology.